Juan Sanabria
Stock Analyst at BMO Capital
(2.19)
# 2,684
Out of 4,868 analysts
91
Total ratings
54.17%
Success rate
3.32%
Average return
Main Sectors:
Stocks Rated by Juan Sanabria
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ELS Equity LifeStyle Properties | Maintains: Outperform | $78 → $77 | $63.07 | +22.09% | 2 | Apr 22, 2025 | |
SKT Tanger | Initiates: Market Perform | $36 | $29.88 | +20.48% | 1 | Jan 28, 2025 | |
CTRE CareTrust REIT | Downgrades: Market Perform | $34 → $32 | $29.88 | +7.10% | 3 | Dec 9, 2024 | |
OHI Omega Healthcare Investors | Upgrades: Outperform | $45 | $37.00 | +21.62% | 3 | Dec 9, 2024 | |
BRX Brixmor Property Group | Upgrades: Outperform | $30 → $33 | $25.79 | +27.96% | 2 | Dec 6, 2024 | |
CUBE CubeSmart | Downgrades: Market Perform | $50 → $47 | $42.71 | +10.04% | 11 | May 29, 2024 | |
PSA Public Storage | Maintains: Outperform | $325 → $330 | $290.81 | +13.48% | 3 | Mar 19, 2024 | |
NHI National Health Investors | Upgrades: Outperform | $67 | $70.84 | -5.42% | 1 | Mar 12, 2024 | |
PECO Phillips Edison & Company | Maintains: Market Perform | $37 → $40 | $35.34 | +13.19% | 2 | Dec 15, 2023 | |
HR Healthcare Realty Trust | Maintains: Market Perform | $20 → $17 | $15.05 | +12.96% | 1 | Oct 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $38 | $35.33 | +7.56% | 5 | Dec 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $45 | $33.75 | +33.33% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $46 | $36.52 | +25.96% | 1 | Apr 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $70 → $75 | $32.82 | +128.52% | 3 | Dec 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 → $82 | $70.72 | +15.95% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $145 | $95.62 | +51.64% | 1 | Dec 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $100 | $153.18 | -34.72% | 3 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $60 | $62.70 | -4.31% | 4 | Aug 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $20 → $21 | $18.28 | +14.88% | 8 | May 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $160 | $146.45 | +9.25% | 7 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $6.35 | +151.97% | 1 | Apr 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $120 → $125 | $157.10 | -20.43% | 1 | Apr 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $266 → $273 | $284.01 | -3.88% | 5 | Nov 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $8.52 | - | 3 | May 18, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $462.81 | - | 6 | Mar 1, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $41.12 | +2.14% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $197 → $198 | $206.52 | -4.13% | 4 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $104 | $115.62 | -10.05% | 1 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $76 | $68.87 | +10.35% | 2 | Jun 8, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $17.05 | +5.57% | 1 | Mar 8, 2018 |
Equity LifeStyle Properties
Apr 22, 2025
Maintains: Outperform
Price Target: $78 → $77
Current: $63.07
Upside: +22.09%
Tanger
Jan 28, 2025
Initiates: Market Perform
Price Target: $36
Current: $29.88
Upside: +20.48%
CareTrust REIT
Dec 9, 2024
Downgrades: Market Perform
Price Target: $34 → $32
Current: $29.88
Upside: +7.10%
Omega Healthcare Investors
Dec 9, 2024
Upgrades: Outperform
Price Target: $45
Current: $37.00
Upside: +21.62%
Brixmor Property Group
Dec 6, 2024
Upgrades: Outperform
Price Target: $30 → $33
Current: $25.79
Upside: +27.96%
CubeSmart
May 29, 2024
Downgrades: Market Perform
Price Target: $50 → $47
Current: $42.71
Upside: +10.04%
Public Storage
Mar 19, 2024
Maintains: Outperform
Price Target: $325 → $330
Current: $290.81
Upside: +13.48%
National Health Investors
Mar 12, 2024
Upgrades: Outperform
Price Target: $67
Current: $70.84
Upside: -5.42%
Phillips Edison & Company
Dec 15, 2023
Maintains: Market Perform
Price Target: $37 → $40
Current: $35.34
Upside: +13.19%
Healthcare Realty Trust
Oct 6, 2023
Maintains: Market Perform
Price Target: $20 → $17
Current: $15.05
Upside: +12.96%
Dec 16, 2022
Downgrades: Underperform
Price Target: $38
Current: $35.33
Upside: +7.56%
Apr 14, 2022
Initiates: Market Perform
Price Target: $45
Current: $33.75
Upside: +33.33%
Apr 14, 2022
Initiates: Outperform
Price Target: $46
Current: $36.52
Upside: +25.96%
Dec 13, 2021
Upgrades: Outperform
Price Target: $70 → $75
Current: $32.82
Upside: +128.52%
Dec 1, 2021
Upgrades: Outperform
Price Target: $80 → $82
Current: $70.72
Upside: +15.95%
Dec 1, 2021
Upgrades: Outperform
Price Target: $145
Current: $95.62
Upside: +51.64%
Aug 26, 2021
Upgrades: Outperform
Price Target: $100
Current: $153.18
Upside: -34.72%
Aug 26, 2021
Upgrades: Market Perform
Price Target: $60
Current: $62.70
Upside: -4.31%
May 21, 2021
Upgrades: Outperform
Price Target: $20 → $21
Current: $18.28
Upside: +14.88%
May 14, 2021
Downgrades: Market Perform
Price Target: $160
Current: $146.45
Upside: +9.25%
Apr 16, 2021
Initiates: Outperform
Price Target: $16
Current: $6.35
Upside: +151.97%
Apr 15, 2021
Maintains: Market Perform
Price Target: $120 → $125
Current: $157.10
Upside: -20.43%
Nov 16, 2020
Maintains: Buy
Price Target: $266 → $273
Current: $284.01
Upside: -3.88%
May 18, 2020
Downgrades: Underperform
Price Target: n/a
Current: $8.52
Upside: -
Mar 1, 2019
Downgrades: Neutral
Price Target: n/a
Current: $462.81
Upside: -
Jun 8, 2018
Maintains: Buy
Price Target: $41 → $42
Current: $41.12
Upside: +2.14%
Jun 8, 2018
Maintains: Neutral
Price Target: $197 → $198
Current: $206.52
Upside: -4.13%
Jun 8, 2018
Maintains: Buy
Price Target: $103 → $104
Current: $115.62
Upside: -10.05%
Jun 8, 2018
Maintains: Buy
Price Target: $74 → $76
Current: $68.87
Upside: +10.35%
Mar 8, 2018
Maintains: Buy
Price Target: $20 → $18
Current: $17.05
Upside: +5.57%